| 2025年年报 | 2025年中报 | 2024年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 药物纯化(元) | 271,557,352.89 | 120,488,307.24 | 187,295,338.31 |
| 药物分析(元) | 130,003,794.71 | 61,475,663.66 | 126,828,218.77 |
| 营业成本(元) | |||
| 药物纯化(元) | 83,473,438.62 | 38,482,190.03 | 59,762,066.18 |
| 药物分析(元) | 31,565,201.21 | 15,112,441.63 | 31,535,328.09 |
| 毛利(元) | |||
| 药物纯化(元) | 188,083,914.27 | 82,006,117.21 | 127,533,272.13 |
| 药物分析(元) | 98,438,593.50 | 46,363,222.03 | 95,292,890.68 |
| 毛利率(%) | |||
| 药物纯化(%) | 69.26 | 68.06 | 68.09 |
| 药物分析(%) | 75.72 | 75.42 | 75.14 |
| 收入构成(%) | |||
| 药物纯化(%) | 67.63 | 66.22 | 59.62 |
| 药物分析(%) | 32.37 | 33.78 | 40.38 |
| 毛利构成(%) | |||
| 药物纯化(%) | 65.64 | 63.88 | 57.23 |
| 药物分析(%) | 34.36 | 36.12 | 42.77 |